We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-12.36%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$12.7B
AUM Growth
-$3.96B
Cap. Flow
-$1.66B
Cap. Flow %
-13.11%
Top 10 Hldgs %
14.02%
Holding
2,200
New
84
Increased
771
Reduced
1,166
Closed
158
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PACB icon
1051
Pacific Biosciences
PACB
$370M
$1.43M 0.01%
324,376
-125,732
-28% -$764K
VUZI icon
1052
Vuzix
VUZI
$224M
$1.43M 0.01%
201,869
-8,396
-4% -$49.3K
CUBE icon
1053
CubeSmart
CUBE
$9.41B
$1.43M 0.01%
33,522
-10,548
-24% -$485K
SQM icon
1054
Sociedad Química y Minera de Chile
SQM
$20.6B
$1.43M 0.01%
17,059
+180
+1% +$15.8K
MGEE icon
1055
MGE Energy Inc
MGEE
$3.08B
$1.42M 0.01%
18,293
-2,622
-13% -$209K
WCN
1056
Waste Connections
WCN
$42B
$1.42M 0.01%
11,482
-100
-0.9% -$13K
DPG
1057
Duff & Phelps Utility and Infrastructure Fund
DPG
$524M
$1.42M 0.01%
102,130
+34,551
+51% +$506K
EWBC icon
1058
East-West Bancorp
EWBC
$18B
$1.42M 0.01%
21,920
-14,044
-39% -$1.01M
IOVA icon
1059
Iovance Biotherapeutics
IOVA
$2.87B
$1.42M 0.01%
128,551
+15,438
+14% +$202K
TPL icon
1060
Texas Pacific Land
TPL
$23.5B
$1.41M 0.01%
8,532
+639
+8% +$104K
BABA icon
1061
Alibaba
BABA
$308B
$1.4M 0.01%
12,335
+2,048
+20% +$201K
STE icon
1062
Steris
STE
$23.1B
$1.4M 0.01%
6,801
-4,915
-42% -$1.11M
BLDR icon
1063
Builders FirstSource
BLDR
$8.04B
$1.4M 0.01%
26,027
-1,546
-6% -$94.8K
GGB icon
1064
Gerdau
GGB
$9.7B
$1.4M 0.01%
410,272
+19,540
+5% +$86.9K
CEM
1065
DELISTED
ClearBridge MLP and Midstream Fund Inc.
CEM
$1.4M 0.01%
48,570
-17,846
-27% -$599K
ACHC icon
1066
Acadia Healthcare
ACHC
$2.94B
$1.39M 0.01%
20,579
-736
-3% -$51.3K
RGR icon
1067
Sturm, Ruger & Co
RGR
$593M
$1.39M 0.01%
21,853
+3,867
+22% +$260K
FDS icon
1068
Factset
FDS
$10.2B
$1.39M 0.01%
3,614
-14,915
-80% -$5.84M
RCL icon
1069
Royal Caribbean
RCL
$85.6B
$1.39M 0.01%
39,799
-8,654
-18% -$538K
CP icon
1070
Canadian Pacific Kansas City
CP
$80.5B
$1.39M 0.01%
19,884
-904
-4% -$65.5K
CCOI icon
1071
Cogent Communications
CCOI
$508M
$1.39M 0.01%
22,816
+420
+2% +$25.8K
SAM icon
1072
Boston Beer
SAM
$1.92B
$1.38M 0.01%
4,552
+161
+4% +$56K
TRTN
1073
DELISTED
Triton International Limited
TRTN
$1.38M 0.01%
26,183
-1,737
-6% -$105K
SJNK icon
1074
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.76B
$1.38M 0.01%
57,061
+12,699
+29% +$321K
GLV
1075
Clough Global Dividend & Income Fund
GLV
$78.1M
$1.37M 0.01%
168,840
+16,765
+11% +$146K

Similar funds

Guggenheim Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Guggenheim Capital held 2,200 positions worth $12.7B, down 24% from $16.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Guggenheim Capital withdrew a net $1.66B in Q2 2022, closing 158 positions and reducing 1,166 holdings. Its most notable exit was BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC, an estimated $13.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Guggenheim Capital opened a new position in ESAB worth $3.14M.

  • Guggenheim Capital's largest Q2 2022 buy was ESAB: 71,750 shares worth $3.14M.
  • Guggenheim Capital added most to Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q2 2022, an estimated $25.1M increase.
  • Guggenheim Capital's biggest Q2 2022 reduction was Apple, cutting an estimated $68.5M.
  • Guggenheim Capital fully exited BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC in Q2 2022, selling an estimated $13.1M.
  • Guggenheim Capital's ten largest holdings make up 14% of its $12.7B portfolio in Q2 2022.
  • Guggenheim Capital opened 84 new positions and closed 158 in Q2 2022.
  • Guggenheim Capital's portfolio value fell 24% quarter-over-quarter to $12.7B.

Based on Guggenheim Capital's 13F filing for Q2 2022, filed 15 Aug 2022.